The Innovative Molecular Analysis Technologies Program (IMAT) was established in 1998 to meet the challenge goal of reducing suffering and death due to cancer. IMAT supports research projects aimed at developing creative methods and tools by which to understand, prevent, diagnose, and treat cancer. Through solicitation, outreach, and communication with the investigator community, the IMAT Program has been successful in promoting cancer-relevant applications of a diverse spectrum of new and emerging technologies. more

Innovative Technologies for
the Molecular Analysis of Cancer
IMAT funding opportunities are designed to encourage applications from individuals and groups interested in developing novel technologies suitable for the molecular analysis of cancers and their host environment in support of basic, clinical, and epidemiological research. more

Application of Emerging
Technologies for Cancer Research
Emerging Technologies funding opportunities are intended to support projects to evaluate the usefulness of emerging technologies in appropriate biological contexts in order to assess reproducibility and produce preliminary data toward a biological or clinical question. more

Innovations in Cancer Sample Preparation
Sample preparation methods and technologies may be developed for sample collection, processing, isolation, storage, purification, preservation, and, in the case of stored tissues, reversal of adverse events resulting from storage and preservation. more

New Related Funding Opportunities

The Innovative Molecular Analysis Technologies (IMAT) program now encompasses an array of 11 closely related Funding Opportunity Announcements (FOAs). Each FOA is segregated based on theme and type of funding mechanism. Click on the links below to view the FOAs by IMAT Program.

Registration now open for the Ninth Principal Investigators Meeting for the IMAT Program. The meeting will be held October, 26-28, 2008, at the Hyatt Regency Cambridge, in Cambridge, MA. For more information and to register, please click here

Funding opportunity announcements for 2008 have been published. The specific receipt dates for the 2008 RFAs are posted below.

To learn more about the latest FOAs, click here.

Receipt dates for IMAT Program R21 and R33 FOAs are as follows:
September 24, 2008

Receipt dates for IMAT Program SBIR and STTR FOAs are as follows:
September 24, 2008

The IMAT program is pleased to announce the renewal of this highly successful and competitive technology development initiative.
The program has received approval from both the Executive Committee of the National Cancer Institute as well as its Board of Scientific Advisors for a 5-year continuation of the program and its related funding opportunities. Pursuant to the program's reissuance, new funding opportunities and funding opportunity announcements are currently being planned and synthesized. Additional details will be posted as they become available and all applicants or potential applicants are encouraged to check back soon for details.

Eighth Principal Investigators Meeting for the IMAT Program was held July 24-25, 2007 in Redwood City, CA. Click here for highlights on this meeting.